Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.
Sakamoto K, Kawamura M, Kohro T, Omura M, Watanabe T, Ashidate K, Horiuchi T, Hara H, Sekine N, Chin R, Tsujino M, Hiyoshi T, Tagami M, Tanaka A, Mori Y, Inazawa T, Hirano T, Yamazaki T, Shiba T; RESEARCH Study Group. Sakamoto K, et al. Among authors: inazawa t. PLoS One. 2015 Sep 23;10(9):e0138332. doi: 10.1371/journal.pone.0138332. eCollection 2015. PLoS One. 2015. PMID: 26398887 Free PMC article. Clinical Trial.
RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale.
Inazawa T, Sakamoto K, Kohro T, Iijima R, Kitazawa T, Hirano T, Kawamura M, Tagami M, Tanaka A, Mori Y, Yamazaki T, Shiba T; RESEARCH Study Group. Inazawa T, et al. Lipids Health Dis. 2013 Oct 5;12:142. doi: 10.1186/1476-511X-12-142. Lipids Health Dis. 2013. PMID: 24094079 Free PMC article. Clinical Trial.
Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24-week, open-label, controlled trial (STOP-OB).
Kitazawa T, Seino H, Ohashi H, Inazawa T, Inoue M, Ai M, Fujishiro M, Kuroda H, Yamada M, Anai M, Ishihara H. Kitazawa T, et al. Among authors: inazawa t. Diabetes Obes Metab. 2020 Sep;22(9):1659-1663. doi: 10.1111/dom.14059. Epub 2020 May 7. Diabetes Obes Metab. 2020. PMID: 32314464 Free PMC article. Clinical Trial.
Comparison of three α-glucosidase inhibitors for glycemic control and bodyweight reduction in Japanese patients with obese type 2 diabetes.
Sugihara H, Nagao M, Harada T, Nakajima Y, Tanimura-Inagaki K, Okajima F, Tamura H, Inazawa T, Otonari T, Kawakami M, Oikawa S. Sugihara H, et al. Among authors: inazawa t. J Diabetes Investig. 2014 Mar 23;5(2):206-12. doi: 10.1111/jdi.12135. Epub 2013 Oct 25. J Diabetes Investig. 2014. PMID: 24843762 Free PMC article.
Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy.
Ishihara H, Anai M, Seino H, Kitazawa T, Ohashi H, Ai M, Inoue M, Fujishiro M, Inazawa T, Kuroda H, Yamada M. Ishihara H, et al. Among authors: inazawa t. Diabetes Ther. 2018 Oct;9(5):2117-2125. doi: 10.1007/s13300-018-0491-4. Epub 2018 Aug 25. Diabetes Ther. 2018. PMID: 30145651 Free PMC article.
Systemic Sarcoidosis with Thyroid Involvement.
Okuma H, Hashimoto K, Wang X, Ohkiba N, Murooka N, Akizuki N, Inazawa T, Ogawa Y. Okuma H, et al. Among authors: inazawa t. Intern Med. 2017 Aug 15;56(16):2181-2186. doi: 10.2169/internalmedicine.8324-16. Epub 2017 Aug 1. Intern Med. 2017. PMID: 28781308 Free PMC article. Review.
[Discussion meeting on appropriate use of laboratory examination].
Suwabe A, Yokoyama N, Inazawa T, Hatsuno T, Kamba S. Suwabe A, et al. Among authors: inazawa t. Nihon Naika Gakkai Zasshi. 2013 Dec 10;102(12):3190-202. doi: 10.2169/naika.102.3190. Nihon Naika Gakkai Zasshi. 2013. PMID: 24605569 Review. Japanese. No abstract available.
Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer.
Kuwabara K, Nishishita T, Morishita M, Oyaizu N, Yamashita S, Kanematsu T, Obara T, Mimura Y, Inoue Y, Kaminishi M, Kaga K, Amino N, Kitaoka M, Ito K, Miyauchi A, Noguchi S, Uchimaru K, Akagawa E, Watanabe N, Takahashi TA, Sato K, Inazawa T, Nakaoka T, Yamashita N. Kuwabara K, et al. Among authors: inazawa t. Thyroid. 2007 Jan;17(1):53-8. doi: 10.1089/thy.2006.0178. Thyroid. 2007. PMID: 17274750 Clinical Trial.
29 results